The Promising Future of Alzheimer Disease Treatment
Panelists conclude the discussion with personal insight into the promising future of Alzheimer disease treatment.
Disease-Modifying Therapy: Defining Response
Expert panelists consider how to define response to disease-modifying therapies and discuss the threshold for treatment ineligibility due to lack of response.
The American Brain Foundation: Driving AD Treatment Development
A member of the American Brain Foundation discusses the organization’s role in the development of Alzheimer disease management and improvement in education.
Offsetting the Increased Cost of AD Treatment
Key opinion leaders discuss possible ways to mitigate the increased cost of Alzheimer disease treatment.
Stratifying Patients for Treatment Eligibility
A discussion on the stratification of patient populations for treatment eligibility based on various decision factors.
Developing Policies for Early Biomarker Detection
Panelists discuss how to craft future policies for early biomarker detection to use developing therapies that target underlying pathophysiology.
Improving Access to Appropriate AD Care
Key opinion leaders consider effective ways to improve access to appropriate care for individuals with Alzheimer disease.
Improved Tracking of AD Comorbidities and Progression
Expert panelists discuss methods to better monitor comorbidities and adverse effects associated with Alzheimer disease.
Goals of AD Therapy With Early Detection
Experts in the management of Alzheimer disease consider the future goals of therapy in tandem with the development of early detection polices.
Diagnostic Process for Individuals With Suspected AD
A discussion on the typical journey of a patient with Alzheimer disease from initial presentation to proper diagnosis within the health care system.
Key Drivers for Health Care Utilization and Spending
Key opinion leaders discuss which factors contribute to patients and caregivers deciding to seek health care guidance and assistance for Alzheimer disease.
Health Inequities Among Patient Populations With AD
A discussion on the disparity in access to quality health care between various patient populations.
Increased Prevalence of Alzheimer Disease
Experts in the management of Alzheimer disease consider the increased prevalence of Alzheimer disease in the United States with growing geriatric populations and how the health care system is adapting.
Patient Journey to Health Care System and Diagnosis
Panelists consider at what point in the disease development patients typically access the health care system for diagnosis and treatment.
Unmet Needs in Treatment of Alzheimer Disease
A discussion on the various unmet needs in the treatment of Alzheimer disease.
Alzheimer Disease: Clinical Burden and Treatment
Key opinion leaders discuss the clinical burden for a patient with Alzheimer disease and enumerate available drug and nondrug treatment options.
2 Clarke Drive Cranbury, NJ 08512